ATS 2020 Advance Program

12:55 The Good: Immunotherapy in Lung Cancer from Neo-Adjuvant to Advanced-Stage Disease T. Peikert, MD, Rochester, MN 1:20 The Bad: Recognizing and Managing Immune-Related Toxicity K. Suresh, MD, Baltimore, MD 1:45 Targeted Therapy in Stage IV Disease S. Patel, MD, MSc, Raleigh, NC 2:05 Break 2:20 Oligometastatic Disease M.P. Rivera, MD, ATSF, Chapel Hill, NC 2:45 Typical and Atypical Carcinoid: How Are They Even Related D.J. Feller-Kopman, MD, Baltimore, MD 3:10 Lung Cancer in the Elderly, Minority and Female Populations C. Langer, MD, Philadelphia, PA 3:35 Lung Cancer Journal Club: The Year’s Top 5 Manuscripts G.A. Silvestri, MD, Charleston, SC ATS 2020 • Philadelphia, PA 34 SATURDAY • MAY 16